Engineering molecules with artificial intelligence
Chai powers drug discovery programs at the world's leading pharmaceutical companies.
Chai powers drug discovery programs at the world’s leading pharmaceutical companies.
Announcing our Series C
We've raised $400M of new funding to accelerate our work at Chai.
Announcing our Series C
We've raised $400M of new funding to accelerate our work at Chai.
Chai Discovery builds the computer-aided design suite for molecules.
Our models learn the underlying foundations of biochemical structure and interaction, enabling scientists to design new medicines on the computer.
With Chai, the world's leading life sciences companies move faster and pursue targets that other methods can't reach.
Chai Discovery builds the computer-aided design suite for molecules.
Our models learn the principles of biological structure and interaction, and design new molecules from scratch.
With Chai, the world’s leading life sciences companies move faster and pursue targets that other methods can’t reach.
We’re building a future where new medicines can be designed with the precision and speed of modern engineering.
Join us and contribute to one of the most meaningful challenges in AI.
© 2026 All rights reserved.
© 2026 All rights reserved.
